BIOMAT Database Logo BIOMAT Database Logo

High-performance liquid chromatographic analysis of naloxone in human serum. 1984

M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen

UI MeSH Term Description Entries
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes

Related Publications

M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High-performance liquid chromatographic analysis of glycoamines in serum.
June 1994, Journal of chromatography. B, Biomedical applications,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High-performance liquid chromatographic analysis of indomethacin in serum.
August 1990, Journal of clinical pharmacy and therapeutics,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High performance liquid chromatographic analysis of cimetidine in serum.
January 1979, Therapeutic drug monitoring,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High-performance liquid-chromatographic analysis for tryptophan in serum.
November 1977, Clinical chemistry,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High-performance liquid chromatographic assay of rifampicin in human serum.
February 1990, Journal of chromatography,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High-performance liquid chromatographic determination of nifurtimox in human serum.
December 1988, Journal of chromatography,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High-performance liquid chromatographic determination of bupivacaine in human serum.
August 1984, Journal of chromatography,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High performance liquid chromatographic determination of paracetamol in human serum.
January 1986, Annales de biologie clinique,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High performance liquid chromatographic determination of ketoconazole in human serum.
December 1986, The Journal of antimicrobial chemotherapy,
M D Terry, and G H Hisayasu, and J W Kern, and J L Cohen
High-performance liquid chromatographic-amperometric determination of naloxone hydrochloride injection.
August 1984, Journal of chromatography,
Copied contents to your clipboard!